October 18

ZUTPHEN, The Netherlands, October 18, 2011 - Cryo-Save becomes the first stem cell bank operating in India to receive the WHO-GMP certification In a country where lack of stringent regulations has been causing the general public to view stem cell banking with a certain degree of trepidation, there is reason to cheer.

ABU DHABI, UAE, October 18, 2011 - The Parthenon Group to present extensive regional education report exclusively at Building Future Education MENA 2011 The value of investment opportunities available in the private K-12 education sector in the GCC could potentially reach US$ 3.5 billion in 2012, according to an exclusive study done by The Parthenon Group, the leading strategic advisor to the global education industry.

NEWCASTLE-UPON-TYNE, England, October 18, 2011 - HIGHLIGHTS Completed sales of 4,922 homes (2010 - 4,595) Average price achieved 175,613 (2010 - 163,175) Total Group turnover of 886.1m (2010 - 768.3m) Profit before taxation 67.2m (2010 - 44.4m) Earnings per ordinary share of 41.5p (2010 - 29.7p) Final dividend for the year 8.8p (2010 - 6.7p) Forward order book at 30 September of 418.8m (2010 - 396.7m) Chairman Howard Dawe said "against a backdrop of ongoing economic uncertainty"...the Group..."has performed very well in the year ended 31 July 2011".

OXFORD, England, October 18, 2011 - -- Third ocular product partnered with Sanofi approved to enter clinical development -- Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for the Phase I/IIa clinical development of UshStat, a novel gene-based treatment for Usher syndrome type 1B.

LONDON, October 18, 2011 - ISACO, a company that provides a premium investment service called Shadow Investing is moving its head office.